sec filing
AB
NASDAQ · ABUS
Arbutus Biopharma Corporation
Healthcare · Biotechnology
$4.77
Up+$0.44 (+9.22%)
Updated Aug 22, 2026, 1:04 AM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 896.23M
- P/E ratio
- -21.14
- Dividend yield
- 0.00%
- 52-week range
- $4.01 – $5.38
- Volume
- 1.27M
- Avg. volume
- 1.58M
Price performance
ABUS price history
1M range · 20 trading sessions · Daily adjusted prices
ABUS closed at $4.77 after 20 trading sessions, up 8.90% for the selected period.
- Last close
- $4.77
- Period change
- +8.90%
- Period low
- $4.29
- Period high
- $4.98
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 20, 2026 | $4.92 | $4.96 | $4.74 | $4.77 | 1.27M |
| Aug 19, 2026 | $4.83 | $5.18 | $4.83 | $4.98 | 3.43M |
| Aug 18, 2026 | $4.79 | $4.85 | $4.645 | $4.84 | 1.45M |
| Aug 17, 2026 | $4.66 | $4.795 | $4.6305 | $4.71 | 1.39M |
| Aug 14, 2026 | $4.60 | $4.71 | $4.55 | $4.67 | 1.44M |
| Aug 13, 2026 | $4.56 | $4.65 | $4.505 | $4.58 | 1.39M |
| Aug 12, 2026 | $4.59 | $4.635 | $4.42 | $4.59 | 1.4M |
| Aug 11, 2026 | $4.60 | $4.72 | $4.60 | $4.67 | 1.05M |
| Aug 10, 2026 | $4.59 | $4.665 | $4.545 | $4.59 | 969.22K |
| Aug 7, 2026 | $4.57 | $4.65 | $4.53 | $4.63 | 796.1K |
| Aug 6, 2026 | $4.57 | $4.64 | $4.45 | $4.54 | 1.27M |
| Aug 5, 2026 | $4.46 | $4.69 | $4.45 | $4.62 | 1.7M |
| Aug 4, 2026 | $4.38 | $4.50 | $4.38 | $4.42 | 958.76K |
| Aug 3, 2026 | $4.34 | $4.425 | $4.31 | $4.36 | 1.42M |
| Jul 31, 2026 | $4.40 | $4.4495 | $4.27 | $4.34 | 1.17M |
| Jul 30, 2026 | $4.30 | $4.42 | $4.26 | $4.41 | 786.24K |
| Jul 29, 2026 | $4.41 | $4.43 | $4.27 | $4.29 | 2.08M |
| Jul 28, 2026 | $4.50 | $4.50 | $4.375 | $4.41 | 633.62K |
| Jul 27, 2026 | $4.41 | $4.525 | $4.40 | $4.41 | 977.8K |
| Jul 24, 2026 | $4.46 | $4.51 | $4.37 | $4.38 | 876.89K |
Latest ABUS news
The latest Smart Investors Daily articles mentioning ABUS.
Stock researchResearch & News · SEC Filings
Loading stock research…